Akorn Inc $37.74

up +0.19


22/8/2014 04:00 PM  |  NASDAQ : AKRX  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get AKRX Trend Analysis - it has outperformed the S&P 500 by 109%

Partner Headlines

  1. Stock Futures Steer Higher; Dollar General, Akorn Rising

    IBD
  2. Weekly CEO Sells Highlight: Akorn Inc, Under Armour Inc, Anadarko Petroleum ...

    GuruFocus
  3. Apple, Lithia Motors Test Key Support Areas

    IBD
  4. Akorn Trading Goes Wild On Q2 Report, Finds Support

    IBD
  5. Drugmaker Q2 Profits Robust

    IBD
  6. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  7. Stocks Sag In Rising Trade; Archer Daniels And Avis Rise

    IBD
  8. Actavis Guidance Disappoints; Akorn Beats And Raises

    IBD
  9. Stock Futures Grope Lower; Gannett Surges On Plan To Split

    IBD
  10. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  11. Stocks Close Higher But Volume Declines

    IBD
  12. 5 Drug Companies Profiting From Generics

    Benzinga
  13. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  14. Market Loses Its Swagger In Afternoon Trade

    IBD
  15. Stocks Recover From Early Fade; Whiting Hits New High

    IBD
  16. Stocks Recover Impressively; Gap Slumps In After Hours

    IBD
  17. Stocks Claw Way Back After Morning Sell-Off

    IBD
  18. Stocks Add To Losses; TAL Education Bucks Weakness

    IBD
  19. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  20. Pharmas Soar To New Highs

    IBD
  21. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  22. S&P 500, Dow At New Highs; 14-Year High For Nasdaq

    IBD
  23. Stocks Rise In Strong Turnover; Netflix Soars On Upgrade

    IBD
  24. Akorn Shares Rally Following Increased Price Target

    Benzinga
  25. Stocks Add To Gains; Salix, Akorn Ramp Higher

    IBD
  26. Benzinga's Volume Movers

    Benzinga
  27. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  28. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  29. Stocks Hitting 52-Week Highs

    Benzinga
  30. Stocks Give Up Gains; Volume Picks Up

    IBD
  31. Indexes Mixed As Stocks Pare Earlier Gains

    IBD
  32. Akorn

    IBD
  33. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD
  34. Akorn Shares Gaining On $41 Million Sale Of Branded Drugs Unit To Valeant

    Benzinga
  35. Stocks Fall Modestly; Lufthansa Warning Nails Airlines

    IBD
  36. Several IBD 50 Names Set Up In Stock Picker's Market

    IBD
  37. Lannett Tops Trio Of Medical Small Cap Leaders

    IBD
  38. UPDATE: Bank Of America Reiterates On Akorn As Diverse Niche Player

    Benzinga
  39. Stocks End Mixed; S&P 500 Marks All-Time Closing High

    IBD
  40. Merck Sells Japan Eye-Treatment Rights

    FoxBusiness
  41. Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ROA

    Benzinga
  42. Benzinga's Weekend M&A Chatter

    Benzinga
  43. Akorn Acquires VersaPharm

    IBD
  44. IBD 50 High-Growth Shares Remain In Correction

    IBD
  45. Stocks Close Higher After Late Boost; Air Lease Gains

    IBD
  46. Stocks Go From Red To Green; Akorn Up On Acquisition

    IBD
  47. Akorn Buying VersaPharm To Beef Up Topical Offerings

    IBD
  48. UPDATE: Akorn Acquires VersaPharm For $440M

    Benzinga
  49. Akorn

    IBD
  50. Akorn Q1 EPS Beats, Raises Full-Year Profit Outlook

    IBD
Trading Center